Now that the positive trofinetide results are now in ,the focus now turns to NNZ 2591,the return on trofinetide is potentially very good but the jewel in the crown in Jon Pilcher’s opinion is NNZ2591 .There are 3 indications to go into Phase 2 trials within the next couple of months with Prader Willi not far after that .Jon discussed in the recent update that they will certainly be looking for many more indications to test in the pursuit of NNZ2591 .So 2022 could be a very exciting year for NNZ2591 and Neuren !!!!
Focus now on NNZ2591
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2680 | $19.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 362 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |